MMSI · XBRL financial data

Merit Medical Systems financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (MMSI's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	964	1,075	1,151	1,257	1,357	1,516
Cost of goods and services sold	563	589	632	673	713	778
Gross profit	401	485	519	584	643	738
Selling, general and administrative	298	336	343	374	400	455
Total operating expenses	403	424	432	460	488	554
Operating income (loss)	(2)	61	88	124	156	185
Interest expense	10	5	6	16	31	26
Other income (expense)	(2)	(3)	1	1	(1)	(2)
Income tax expense (benefit)	(3)	5	8	18	30	42
Net income (loss)	(10)	48	75	94	120	128
Earnings per share, basic USD per share	(0.18)	0.86	1.31	1.64	2.07	2.17
Earnings per share, diluted USD per share	(0.18)	0.84	1.29	1.62	2.03	2.13
Weighted average shares, basic millions of shares	55	56	57	58	58	59
Weighted average shares, diluted millions of shares	55	57	58	58	59	60

Fiscal years (MMSI's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	57	68	58	587	377	446
Accounts receivable	147	152	165	178	190	204
Inventory	198	222	266	304	306	334
Prepaid and other current assets	13	16	22	24	29	31
Total current assets	430	482	529	1,108	924	1,040
Property and equipment, net	383	372	383	384	386	428
Right-of-use asset	78	66	65	63	66	88
Goodwill	364	362	360	382	464	507
Total assets	1,664	1,648	1,664	2,325	2,419	2,686
Accrued liabilities	112	159	123	120	134	159
Current portion of long-term debt	8	8	11	—	—	—
Total current liabilities	185	236	221	204	216	240
Long-term debt	344	234	187	823	730	734
Lease liability, non-current	71	62	60	56	55	77
Total liabilities	706	608	520	1,123	1,039	1,102
Retained earnings	358	406	481	575	696	824
Total stockholders' equity	959	1,040	1,144	1,202	1,379	1,584
Total liabilities and equity	1,664	1,648	1,664	2,325	2,419	2,686
Common shares outstanding (cover page) millions of shares	56	57	57	58	59	59

Fiscal years (MMSI's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(10)	48	75	94	120	128
Stock-based compensation	14	16	18	21	28	43
Depreciation and amortization	94	84	82	90	103	123
Net cash from operating activities	165	147	114	145	221	297
Purchases of property and equipment	46	28	45	34	35	82
Net cash from investing activities	(59)	(37)	(57)	(175)	(369)	(247)
Proceeds from issuing common stock	7	21	20	16	41	28
Proceeds from long-term debt	69	98	215	—	—	—
Repayments of long-term debt	157	207	260	—	—	—
Net cash from financing activities	(96)	(98)	(60)	559	(60)	16
Net change in cash	13	11	(7)	529	(210)	70

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Merit Medical Systems	504	416	65*	59.9M	Q3 FY26 10-QSep 30, 2026
GLAUKOS	162	211	39*	59.2M	Q3 FY26 10-QSep 30, 2026
iRhythm Holdings	247	224	51*	33.0M	Q2 FY26 10-QJun 30, 2026
MSA Safety	200	503	95*	38.6M	Q2 FY26 10-QJun 30, 2026
TransMedics Group	491	190	17*	34.7M	Q2 FY26 10-QJun 30, 2026
Globus Medical	508	790	210*	134.3M	Q2 FY26 10-QJun 30, 2026
Integer Holdings	14	450	37*	34.0M	Q3 FY26 10-QOct 2, 2026
Masimo	125	404	45	52.4M	Q1 FY26 10-QApr 4, 2026
Inspire Medical Systems	191	207	46*	29.0M	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.